313 related articles for article (PubMed ID: 27029061)
1. Lysine demethylase 2A promotes stemness and angiogenesis of breast cancer by upregulating Jagged1.
Chen JY; Li CF; Chu PY; Lai YS; Chen CH; Jiang SS; Hou MF; Hung WC
Oncotarget; 2016 May; 7(19):27689-710. PubMed ID: 27029061
[TBL] [Abstract][Full Text] [Related]
2. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
3. Mammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cells.
Rizwani W; Schaal C; Kunigal S; Coppola D; Chellappan S
PLoS One; 2014; 9(7):e100888. PubMed ID: 25029110
[TBL] [Abstract][Full Text] [Related]
4. Lysine demethylase 2A expression in cancer-associated fibroblasts promotes breast tumour growth.
Chen JY; Li CF; Lai YS; Hung WC
Br J Cancer; 2021 Jan; 124(2):484-493. PubMed ID: 33024266
[TBL] [Abstract][Full Text] [Related]
5. Depletion of histone demethylase KDM2A enhanced the adipogenic and chondrogenic differentiation potentials of stem cells from apical papilla.
Dong R; Yao R; Du J; Wang S; Fan Z
Exp Cell Res; 2013 Nov; 319(18):2874-82. PubMed ID: 23872478
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells.
Dhar SS; Alam H; Li N; Wagner KW; Chung J; Ahn YW; Lee MG
J Biol Chem; 2014 Mar; 289(11):7483-96. PubMed ID: 24482232
[TBL] [Abstract][Full Text] [Related]
7. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.
Liu H; Liu L; Holowatyj A; Jiang Y; Yang ZQ
Mol Carcinog; 2016 May; 55(5):977-90. PubMed ID: 26207617
[TBL] [Abstract][Full Text] [Related]
8. Histone demethylase KDM4C regulates sphere formation by mediating the cross talk between Wnt and Notch pathways in colonic cancer cells.
Yamamoto S; Tateishi K; Kudo Y; Yamamoto K; Isagawa T; Nagae G; Nakatsuka T; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Ikenoue T; Aburatani H; Omata M; Koike K
Carcinogenesis; 2013 Oct; 34(10):2380-8. PubMed ID: 23698634
[TBL] [Abstract][Full Text] [Related]
9. HPV16 E7-induced upregulation of KDM2A promotes cervical cancer progression by regulating miR-132-radixin pathway.
Ou R; Zhu L; Zhao L; Li W; Tao F; Lu Y; He Q; Li J; Ren Y; Xu Y
J Cell Physiol; 2019 Mar; 234(3):2659-2671. PubMed ID: 30132864
[TBL] [Abstract][Full Text] [Related]
10. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
[TBL] [Abstract][Full Text] [Related]
11. Depletion of histone demethylase KDM2A inhibited cell proliferation of stem cells from apical papilla by de-repression of p15INK4B and p27Kip1.
Gao R; Dong R; Du J; Ma P; Wang S; Fan Z
Mol Cell Biochem; 2013 Jul; 379(1-2):115-22. PubMed ID: 23559091
[TBL] [Abstract][Full Text] [Related]
12. HOXA-AS2 contributes to regulatory T cell proliferation and immune tolerance in glioma through the miR-302a/KDM2A/JAG1 axis.
Zhong C; Tao B; Li X; Xiang W; Peng L; Peng T; Chen L; Xia X; You J; Yang X
Cell Death Dis; 2022 Feb; 13(2):160. PubMed ID: 35181676
[TBL] [Abstract][Full Text] [Related]
13. KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.
Wagner KW; Alam H; Dhar SS; Giri U; Li N; Wei Y; Giri D; Cascone T; Kim JH; Ye Y; Multani AS; Chan CH; Erez B; Saigal B; Chung J; Lin HK; Wu X; Hung MC; Heymach JV; Lee MG
J Clin Invest; 2013 Dec; 123(12):5231-46. PubMed ID: 24200691
[TBL] [Abstract][Full Text] [Related]
14. Histone demethylase KDM2A suppresses EGF-TSPAN8 pathway to inhibit breast cancer cell migration and invasion in vitro.
Zhang H; Tu Y; Huang B; Xiao J; Xiao J; Wang J; Pei Y; Yang R; Feng J; Li J; Zhang X
Biochem Biophys Res Commun; 2022 Nov; 628():104-109. PubMed ID: 36084547
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of miR-663a inhibits the cancer stem cell-like properties of glioma via repressing the KDM2A-mediated TGF-β/SMAD signaling pathway.
Wang L; Lang B; Zhou Y; Ma J; Hu K
Cell Cycle; 2021 Oct; 20(19):1935-1952. PubMed ID: 34424812
[TBL] [Abstract][Full Text] [Related]
16. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
[TBL] [Abstract][Full Text] [Related]
17. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
Ramadoss S; Guo G; Wang CY
Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
[TBL] [Abstract][Full Text] [Related]
18. Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas.
De Nicola I; Guerrieri AN; Penzo M; Ceccarelli C; De Leo A; Trerè D; Montanaro L
Histol Histopathol; 2020 Oct; 35(10):1181-1187. PubMed ID: 32901907
[TBL] [Abstract][Full Text] [Related]
19. GATA1-regulated JAG1 promotes ovarian cancer progression by activating Notch signal pathway.
Liu Z; Zhu Y; Li F; Xie Y
Protoplasma; 2020 May; 257(3):901-910. PubMed ID: 31897811
[TBL] [Abstract][Full Text] [Related]
20. Lysine demethylase KDM2A inhibits TET2 to promote DNA methylation and silencing of tumor suppressor genes in breast cancer.
Chen JY; Luo CW; Lai YS; Wu CC; Hung WC
Oncogenesis; 2017 Aug; 6(8):e369. PubMed ID: 28785073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]